Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Researchers discover that antiviral lectins like BOA can effectively inhibit SARS-CoV-2 and its variants by targeting spike glycans, opening doors for potential pan-coronavirus treatments. The study reveals that BOA’s multivalent interactions make it a potent inhibitor against a range of viral variants, offering promise for future therapeutic strategies.

Patient records exposed in data breaches doubled in 2023

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The number of patient records

January 23, 2024

Early warning sign for myeloma found in bone marrow fat cells

A new research perspective was published in Oncotarget’s Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS

January 22, 2024

Vaccines a Major Focus of RFK Jr.’s Senate Confirmation Hearing

The gloves came off at Wednesday’s Senate Finance Committee confirmation hearing for Robert F. Kennedy Jr. as HHS secretary, with Democratic senators grilling Kennedy about

January 30, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.